SCHEMBL3154841

SCHEMBL3154841

C#Cc1cccc(C(COC)c2nc(N)c3cc(OCCOC)c(OCCOC)cc3n2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 12/20 0.48
ERBB2 P04626 4/20 0.48
KDM1A O60341 3/20 0.48
GAK O14976 2/20 0.48
ILK Q13418 2/20 0.48
PLK4 O00444 1/20 0.48
CIT O14578 1/20 0.48
AURKA O14965 1/20 0.48
EPHB6 O15197 1/20 0.48
SLC22A1 O15245 1/20 0.48
DAPK3 O43293 1/20 0.48
RIPK2 O43353 1/20 0.48
BUB1 O43683 1/20 0.48
JAK2 O60674 1/20 0.48
RPS6KA4 O75676 1/20 0.48
STK17B O94768 1/20 0.48
STK10 O94804 1/20 0.48
SLCO2B1 O94956 1/20 0.48
ABCB11 O95342 1/20 0.48
ABL1 P00519 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1979453 0.79 EGFR (0.52) EGFRERBB2KDM1AGAKILK
SCHEMBL29493193 0.79 EGFR (0.52) EGFRERBB2KDM1AGAKILK
Hydrochloric Acid SCHEMBL30963337 0.78 EGFR (0.52) EGFRERBB2KDM1AGAKILK
SCHEMBL14811309 0.77 EGFR (0.55) EGFRERBB2KDM1AGAKILK
SCHEMBL7858883 0.74 EGFR (0.49) EGFRERBB2KDM1AGAKILK
SCHEMBL16212567 0.73 EGFR (0.46) EGFRERBB2KDM1AGAKILK
Hydrochloric Acid SCHEMBL1436789 0.72 EGFR (0.52) EGFRERBB2KDM1AGAKILK
SCHEMBL2841492 0.71 EGFR (0.68) EGFRERBB2KDM1AGAKILK
SCHEMBL2841494 0.68 EGFR (0.66) EGFRERBB2KDM1AGAKILK
SCHEMBL14482031 0.67 EGFR (0.73) EGFRERBB2KDM1AGAKILK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2162444-A2 AN IMPROVED PROCESS FOR ERLOTINIB HYDROCHLORIDE Hetero Drugs Limited (IN) 2010-03-17 EP claimed
WO-2009007984-A2 AN IMPROVED PROCESS FOR ERLOTINIB HYDROCHLORIDE HETERO DRUGS LIMITED (IN) 2009-01-15 WO claimed